MétaCan
Menu
← Retour à la cohorte
Enregistrement W4411420593 · doi:10.1016/j.ard.2025.06.382

POS1028 Long-term response to faecal microbiota transplantation in psoriatic arthritis is associated with gut microbiota community types in recipients

2025· article· en· W4411420593 sur OpenAlexaboutno aff
Peng Qin, Maja Skov Kragsnæs, Dorte Kinggaard Holm, Hans Christian Horn, Anna Christine Nilsson, Jens Kjeldsen, Karsten Kristiansen, Torkell Ellingsen

Notice bibliographique

RevueAnnals of the Rheumatic Diseases · 2025
Typearticle
Langueen
DomaineMedicine
ThématiqueMycobacterium research and diagnosis
Établissements canadiensnon disponible
Organismes subventionnairesnon disponible
Mots-clésMedicinePsoriatic arthritisGut floraFecal bacteriotherapyImmunologyTransplantationPsoriasisReactive arthritisMicrobiomeArthritisClostridium difficileMicrobiologyBioinformaticsInternal medicineBiologyAntibiotics

Résumé

récupéré en direct d'OpenAlex

Background: An abnormal composition of gut bacteria in combination with alterations of microbiota-derived metabolites may be important environmental factors contributing to the natural history of disease and may potentially affect drug responses in immune-mediated conditions. Hence, modulation of the intestinal microbiota is increasingly being highlighted as a potential novel complementary therapy to immunomodulatory drugs. Faecal microbiota transplant (FMT) products contain minimally manipulated microbial communities donated by healthy, thoroughly-screened individuals. In a previous randomised trial (FLORA) investigating safety and efficacy of one FMT in methotrexate (MTX)-treated patients with severe psoriatic arthritis (PsA), we observed transitory beneficial clinical effects within weeks of the intervention, while sustained, long-term effects was only observed in 40% treated [1]. Investigations into biological mechanisms that can explain the observed differences in treatment outcome following FMT in immune-mediated arthritis have not previously been reported. Objectives: We therefore conducted a shotgun metagenomics study to explore how gut bacterial signatures in patients and engraftment of specific strains associated with long-term response to FMT in active PsA. Methods: This exploratory study is based on the FLORA trial cohort encompassing 31 patients with moderate-to-high PsA disease activity and 4 FMT donors. Out of fifteen patients receiving one single-donor FMT (the intention-to-treat population, ITT), thirteen were included in the per-protocol (PP) population. The reasons for excluding two patients from the PP population included major changes in living environment and not receiving the full dose of the FMT product. Stool samples were collected before and after FMT (week 4, 12, and 26). We performed shotgun metagenomics to characterise the gut microbiota features. Results: At baseline, 17 PsA patients (55%) had a gut microbiota community (GMC) type dominated by the Bacteroides genus (B-type) while 14 (45%) had a Prevotella -driven community type (P-type). The B- and P-type patients did not differ in disease activity nor demographics at baseline (Table 1), but B-type patients had a significantly higher species diversity compared to P-type patients (p=0.005). In the PP population, five out of seven B-type patients vs none out of six P-type patients (p=0.021) achieved a long-term clinical beneficial response at week 26. Although this difference was not statistically significant in the ITT population (5 vs 1, p=0.12), the remission rate in B-type patients was still four times higher compared to P-type patients. In B-type patients, strain richness significantly increased from baseline to week 4 (p=0.016) and week 26 (p=0.016) (Figure 1A). In contrast, alpha diversity only showed an increasing trend (p=0.062) at week 4 in P-type patients, and this trend was only temporary, as both alpha diversity (p=0.062) and strain richness (p=0.062) showed a decreasing trend by week 12 (Figure 1A). Eighteen engrafted bacterial strains persisted only in B-type recipients by week 26 (Figure 1B), including a Bacteroides clarus strain, which demonstrated a negative effect size regarding arthritis pain and the physician's global assessment of disease. Table 1. Baseline demographics and disease characteristics of the B and P-type patients. Data are mean (SD) or n (%) unless otherwise stated. a Time since diagnosis of psoriatic arthritis is presented as median and interquartile range (IQR). HAQ-DI, Health Assessment Questionnaire Disability Index. SPARCC, Spondyloarthritis Research Consortium of Canada. DMARD, disease‑modifying anti-rheumatic drug. Figure 1Gut microbiota modifications following one faecal microbiota transplantation (FMT) in B- and P-type patients. B denotes patients with a gut microbiota community (GMC) type dominated by the Bacteroides genus (B-type) at baseline while P denote patients with a Prevotella -driven GMC (P-type). (A) Changes in strain richness and alpha diversity. P values were calculated using paired Wilcox test. (B) Long-term multi-recipient colonization (LMC) strains, defined as strains that engrafted and colonised in at least three patients by week 26. Eighteen LMC strains, which exclusively engrafted in B-type recipients at week 26, are marked with a star and a letter. The colour of the star distinguishes whether the strain colonized short-term in P-type recipients at week 4: purple indicates no colonization at week 4, while pink indicates colonization at week 4. SCFA, short-chain fatty acid Conclusion: This study shows for the first time that a Bacteroides -predominant GMC type (B-type) associates with long-term beneficial response following one FMT in patients with PsA. In contrast to patients having a Prevotella -dominated community type (P-type), strain richness significantly increased in B-type patients, including long-term engraftment of donor-specific bacterial strains. More research is encouraged to evaluate the clinical value of using GMC typing and other gut microbial features in guiding the selection of therapies and enhancing personalised treatment responses in relation to both the application of microbiota-targeted therapies such as FMT and the use of established disease-modifying anti-rheumatic drugs. REFERENCES: [1] Kragsnaes MS, Kjeldsen J, Horn HC, et al . Safety and efficacy of faecal microbiota transplantation for active peripheral psoriatic arthritis: an exploratory randomised placebo-controlled trial. Ann Rheum Dis 2021;80:1158-67. Acknowledgements: NIL . Disclosure of Interests: None declared . © The Authors 2025. This abstract is an open access article published in Annals of Rheumatic Diseases under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Neither EULAR nor the publisher make any representation as to the accuracy of the content. The authors are solely responsible for the content in their abstract including accuracy of the facts, statements, results, conclusion, citing resources etc.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,001
score de la tête « metaresearch » (Gemma)0,001
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: Observationnel
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,002
Score d'incertitude au seuil0,008

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0010,001
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0010,001
Bibliométrie0,0000,001
Études des sciences et des technologies0,0000,000
Communication savante0,0010,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,001
Charge utile insuffisante (le modèle a refusé de juger)0,0020,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,028
Tête enseignante GPT0,331
Écart entre enseignants0,302 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2025
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueAnnals of the Rheumatic Diseases→Même sujetMycobacterium research and diagnosis→Travaux en français237 207→